Skip to main content
Medifocus Inc. logo

Medifocus Inc. — Investor Relations & Filings

Ticker · MFS ISIN · CA58470Q1019 TSXV Manufacturing
Open in API
Filings indexed 9 across all filing types
Latest filing 2022-08-15 Regulatory Filings
Country CA Canada
Listing TSXV MFS

About Medifocus Inc.

https://medifocusinc.com/

Medifocus Inc. develops and commercializes minimally invasive treatment systems utilizing focused heat (thermotherapy) for medical applications. The company's core focus is the treatment of cancerous and benign tumors, as well as enlarged prostate (Benign Prostatic Hyperplasia, or BPH). Medifocus holds a portfolio of medical products, including the Prolieve® Thermodilatation System, which addresses BPH. The company maintains two proprietary technology platforms supported by approximately 100 issued and pending US and international patents.

Recent filings

Filing Released Lang Actions
Material change report - English.pdf
Regulatory Filings Classification · 95% confidence The document is a Form 51-102F3 Material Change Report filed by Medifocus Inc. It details a significant corporate event: the company completed a restructuring transaction under creditor protection proceedings, resulting in acquisition by a secured lender and becoming a private company. It also mentions the company's shares will be delisted from the TSX Venture Exchange. The document is a regulatory announcement of a material change, not a full financial report or earnings release. It is not a report publication announcement since it contains substantive information about the transaction and its consequences. The document fits the definition of a Regulatory Filing (RNS) as it is a general regulatory announcement about a material corporate event that does not fit other specific categories like M&A filings or delisting announcements (the delisting is mentioned but the primary focus is the material change report). Therefore, the best classification is Regulatory Filings (RNS).
2022-08-15 English
News release - English.pdf
Delisting Announcement Classification · 95% confidence The document is a press release announcing the completion of a restructuring transaction involving Medifocus Inc. It details the acquisition by Asset Profits Limited, the consolidation of shares, and the company's delisting from the TSX Venture Exchange. The text includes information about creditor protection proceedings under the Companies’ Creditors Arrangement Act (CCAA), the court-approved sale process, and the company's new status as a private company. There are no financial statements, detailed financial performance data, or comprehensive management analysis present. The document is primarily an announcement of a corporate restructuring event and delisting, not a full financial report or detailed regulatory filing. Therefore, the most appropriate classification is a Delisting Announcement (DLST), as the company explicitly states that its shares will be delisted due to no longer meeting listing requirements.
2022-08-15 English
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a press release announcing that Medifocus Inc. has commenced restructuring proceedings by filing for creditor protection and is considering debtor-in-possession financing and an asset sale process. It discusses the company's financial and strategic review, restructuring plans, and forward-looking statements related to the restructuring. There are no financial statements, detailed financial data, or comprehensive financial performance analysis included. The document is an update on the company's capital and financing situation, specifically about restructuring and potential financing arrangements. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length (8283 characters) supports that it is a substantive announcement rather than a brief notice or a report publication announcement.
2021-09-17 English
News release - English.pdf
Board/Management Information Classification · 100% confidence The document is a short announcement about the resignation of the Chief Financial Officer of Medifocus Inc. It contains no financial data, no report or filing references, and no regulatory or voting information. It is a management change announcement, specifically about a senior executive position. Therefore, it fits the category of Board/Management Information (MANG). The document length is short and focused solely on this personnel change, confirming the classification.
2020-08-24 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing a delay in the filing of the company's annual disclosure documents, specifically the audited annual financial statements and related management's discussion and analysis for the fiscal year ended March 31, 2020. It references regulatory instruments (Ontario Instrument 51-502) and the company's intention to file the required documents by a later date. The document does not contain the actual annual report or financial statements but is an announcement about the delay in filing these reports. The document length is 3430 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, according to the 'Menu vs Meal' rule, this should be classified as a Regulatory Filing (RNS) since it is a regulatory announcement about filing delays and not the report itself.
2020-07-25 English
Certificate re dissemination to shareholders.pdf
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a short communication from TSX Trust Company confirming the mailing of proxy-related materials to securityholders. It lists proxy, voting instruction forms, notice of meeting combined with information circular, and proxy return envelope. There is no actual financial data or report content, only confirmation of distribution of proxy materials. The document length is only 1194 characters, indicating it is an announcement rather than a full report. This fits the category of Proxy Solicitation & Information Statement (PSI) materials being sent to shareholders for voting purposes.
2020-01-27 English

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.